ORLANDO, FL / ACCESSWIRE / May 17, 2022 /Â Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced today it has booked nearly a quarter of a million dollars in new in contract manufacturing orders through its wholly-owned subsidiary Pocono Pharma, extending its current run of record-breaking revenue.
Nutriband Inc. Receives Orders For $230,000 In Contract Manufacturing For First 3 Weeks Of May
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.